This drug, a GLP-1 receptor agonist, is already approved for treating obesity and weight management in conjunction with diet, physical activity, and behavioral support
By integrating daily habits with real-time biometric insights, we can offer a more connected and personalized approach to support lasting resultsnot just in weight on the scale, but in how people feel and function every day. About LillyDirect LillyDirect is a digital health platform designed to connect people living with chronic conditions to the care, support, and prescribed medicines they need
Final Assessment: What This Review Can and Cannot Conclude About FeelGood GLP-1 Everything here comes from publicly available sources: FeelGood's official website, published Terms and Refund Policy, the OpenLoop Healthcare Partners PC telehealth consent, and publicly available FDA and FTC guidance
As demand for new weight loss medications grows, there is increased focus on the insurance coverage landscape